Altimmune ernennt Richard Menziuso zum Principal Accounting Officer und Global Controller

Von Public Technologies11:05 (UTC), 29 September 2026 Aktualisiert

Altimmune ernennt Richard Menziuso per 29. September 2026 zum Vice President, Global Controller und Principal Accounting Officer.
Menziuso war zuletzt Vice President, Corporate Controller bei Centessa Pharmaceuticals bis zur Übernahme 2026 durch Eli Lilly.
Zuvor leitete er Finanz- und Controllingfunktionen bei Thermo Fisher Scientific sowie Axovant Gene Therapies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001326190-26-000056), on September 29, 2026, and is solely responsible for the information contained therein.